Outcomes Evaluated in Controlled Clinical Trials on the Management of COVID-19: A Methodological Systematic Review
Authors:
- Alexander G. MathioudakisAlexander G. Mathioudakis
- Markus FallyMFMarkus Fally
- Rola HashadRHRola Hashad
- Ahmed KoutaAKAhmed Kouta
- Ali Sina HadiAHAli Sina Hadi
- Sean Blandin KnightSKSean Blandin Knight
- Nawar Diar BakerlyNBNawar Diar Bakerly
- Dave SinghDSDave Singh
- Paula R. WilliamsonPWPaula R. Williamson
- Tim FeltonTFTim Felton
- Jørgen VestboJVJørgen Vestbo
Open Access
Abstract
It is crucial that randomized controlled trials (RCTs) on the management of coronavirus disease 2019 (COVID-19) evaluate the outcomes that are critical to patients and clinicians, to facilitate relevance, interpretability, and comparability. This methodological systematic review describes the outcomes evaluated in 415 RCTs on the management of COVID-19, that were registered with ClinicalTrials.gov, by 5 May 2020, and the instruments used to measure these outcomes. Significant heterogeneity was observed in the selection of outcomes and instruments. Mortality, adverse events and treatment success or failure are only evaluated in 64.4%, 48.4% and 43% of the included studies, respectively, while other outcomes are selected less often. Studies focusing on more severe presentations (hospitalized patients or requiring intensive care) most frequently evaluate mortality (72.5%) and adverse events (55.6%), while hospital admission (50.8%) and viral detection/load (55.6%) are most frequently assessed in the community setting. Outcome measurement instruments are poorly reported and heterogeneous. Follow-up does not exceed one month in 64.3% of these earlier trials, and long-term COVID-19 burden is rarely assessed. The methodological issues identified could delay the introduction of potentially life-saving treatments in clinical practice. Our findings demonstrate the need for greater consistency, to enable decision makers to compare and contrast studies.Keywords
All Related Versions
Funding Information
- Manchester Biomedical Research Centre (NIHR Manchester BRC)
This publication has 24 references indexed in Scilit:
- A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbationsERJ Open Research, 2019
- Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trialsERJ Open Research, 2019
- Core Outcome Set-STAndardised Protocol Items: the COS-STAP StatementTrials, 2019
- Reporting of outcomes in gastric cancer surgery trials: a systematic reviewBMJ Open, 2018
- A taxonomy has been developed for outcomes in medical research to help improve knowledge discoveryJournal of Clinical Epidemiology, 2018
- The COMET Handbook: version 1.0Trials, 2017
- Core Outcome Set–STAndards for Reporting: The COS-STAR StatementPLOS Medicine, 2016
- Can a core outcome set improve the quality of systematic reviews? – a survey of the Co-ordinating Editors of Cochrane review groupsTrials, 2013
- A national early warning score for acutely ill patientsBMJ, 2012
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996